Annals On Call Podcast

Annals On Call Podcast

American College of Physicians
Negara Amerika Serikat
Genre Health & Fitness, Medicine
Bahasa EN-US
Episode 192
Terbaru 18.05.2026

Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.

Episode

  • Who Should Receive the RSV Vaccine? 01.06.2026 19mnt
    Dr. Centor discusses the American College of Physicians' recommendations for respiratory syncytial virus vaccination with Dr. Rachael Lee.
  • Preventing Recurrent Nephrolithiasis 18.05.2026 22mnt
    Dr. Centor discusses interventions to prevent kidney stones with Dr. Gary Asher.
  • Clinical Mastery in Primary Care 04.05.2026 18mnt
    Dr. Centor discusses advancing clinical mastery as a strategy to revitalize primary care practice with Dr. Richard Kravitz.
  • Physicians Not Providers 20.04.2026 19mnt
    Dr. Centor discusses why the American College of Physicians believes that physicians should not be called providers with Drs. Robert McLean and Jan Carney.
  • Managing Inpatient Hyponatremia Part 2 06.04.2026 28mnt
    Dr. Centor discusses hyponatremia in the inpatient setting with Dr. Joel Topf.
  • Managing Outpatient Hyponatremia Part 1 16.03.2026 19mnt
    Dr. Centor discusses hyponatremia in the outpatient setting with Dr. Joel Topf.
  • Alzheimer Disease: A Diagnostic Challenge 02.03.2026 21mnt
    Dr. Centor discusses the diagnosis of Alzheimer disease with Dr. Gayatri Devi.
  • Hyponatremia Correction: How Fast Is Too Fast? 16.02.2026 21mnt
    Dr. Centor discusses hyponatremia correction rates with Dr. Dustin Mark.
  • The Role of Corticosteroids in Severe Pneumonia 02.02.2026 20mnt
    Dr. Centor discusses the role of corticosteroids in the treatment of community-acquired pneumonia with Dr. Michael Klompas.
  • Dulaglutide, Semaglutide, and Tirzepatide: How do Gastrointestinal Side Effects Compare? 19.01.2026 21mnt
    Dr. Centor discusses the comparative risk for severe gastrointestinal adverse events associated with dulaglutide, semaglutide, and tirzepatide with Dr. Wajd Alkabbani.
  • Mediterranean Diet in the Management of Irritable Bowel Syndrome 05.01.2026 23mnt
    Dr. Centor discusses dietary interventions for patients with irritable bowel syndrome with Dr. Imran Aziz.
  • Complications Associated With Transvenous Cardiac Implantable Devices 15.12.2025 25mnt
    Dr. Centor discusses complications of cardiac implantable electronic devices with Dr. Peter Zimetbaum.
  • Cost-Effectiveness of Weight Loss Drugs for Knee Osteoarthritis 01.12.2025 25mnt
    Dr. Centor discusses the use of weight loss drugs to treat patients with knee osteoarthritis with Dr. David Felson.
  • Palliative Care: A Family Perspective 17.11.2025 19mnt
    Dr. Centor discusses a family perspective on palliative care with Ms. Monica Wright, the author of an On Being a Patient essay.
  • What You May Have Missed in 2024: Part 3 03.11.2025 15mnt
    Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
  • What You May Have Missed in 2024 - Part 2 20.10.2025 13mnt
    Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
  • High-Concentration Cannabinoids: Are They Safe? 06.10.2025 29mnt
    Dr. Centor discusses currently available evidence about high-concentration cannabis products and mental health outcomes with Drs. Paula Riggs and Jonathan Samet.
  • What You May Have Missed in 2024: Part 1 15.09.2025 20mnt
    Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
  • Fibrillation - When Ablation is the Way to Go 01.09.2025 22mnt
    Dr. Centor discusses the role of ablation in the management of patients with atrial fibrillation with Dr. Peter Zimetbaum.
  • Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes 18.08.2025 29mnt
    Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.